• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性氮质血症对犬呋塞米肾清除率的影响。

Effect of experimental azotemia on renal clearance of furosemide in the dog.

作者信息

Rose H J, Pruitt A W, McNay J L

出版信息

J Pharmacol Exp Ther. 1976 Jan;196(1):238-47.

PMID:1246013
Abstract

The clearance of furosemide (F), whose renal tubular transport shares the classical characteristics of the organic acid system, was determined in dogs with varying degrees of azotemia and compared with tetraethylammonium (TEA), an organic base. Two normal and eight azotemic dogs [blood urea nitrogen (BUN), 12-273] were studied. Azotemia was produced by bilateral uretero-venous anastomoses. The left renal vein and ureter were cannulated and renal blood flow (RBF) was measured by electromagnetic flowmeter. Simultaneous left renal clearances (C) of subpharmacological doses of TEA-14C and furosemide-14C were determined at seven 30-minute intervals. Initial loading doses were followed by continuous maintenance infusions. For TEA, clearance (1.5 ml/min-g +/- 0.2 S.E.M.) and extraction (E) (0.83 +/- 0.02) are independent of the degree of azotemia. Renal plasma flow (RPF), calculated as CTEA/ETEA, agreed closely with directly measured RPF (2.0 ml/g-min +/- 0.3). RPF was independent of azotemia. To allow for individual differences in the animals in RPF, the ratio CTEA/CF was used. CF (1.07-0.17 ml/min-g) and EF (0.54-0.06) decreased as a linear function of the increase in uremic serum: (see article). Furosemide and its principle metabolite were greater than or equal to 97% of the furosemide portion of the radioactivity. The metabolite did not increase with time in either plasma or urine. After acute administration of exogenous urea to two dogs (BUN 170 and 253) CTEA/CF was unrelated to BUN. Thus, the CF decreases proportionately with progressive azotemia and is not related to RBF, exogenous urea or metabolite. This suppression of renal tubular secretion of furosemide may partially account for reduced therapeutic efficacy of furosemide in azotemia.

摘要

速尿(F)的肾小管转运具有有机酸系统的典型特征,研究了不同程度氮质血症犬的速尿清除率,并与有机碱四乙铵(TEA)进行比较。研究了2只正常犬和8只氮质血症犬[血尿素氮(BUN),12 - 273]。氮质血症通过双侧输尿管 - 静脉吻合术产生。将左肾静脉和输尿管插管,用电磁流量计测量肾血流量(RBF)。在7个30分钟的间隔内,同时测定亚药理剂量的TEA - 14C和速尿 - 14C的左肾清除率(C)。初始负荷剂量后进行持续维持输注。对于TEA,清除率(1.5 ml/min - g±0.2标准误)和提取率(E)(0.83±0.02)与氮质血症程度无关。以CTEA/ETEA计算的肾血浆流量(RPF)与直接测量的RPF(2.0 ml/g - min±0.3)密切相符。RPF与氮质血症无关。为了考虑动物RPF的个体差异,使用CTEA/CF比值。CF(1.07 - 0.17 ml/min - g)和EF(0.54 - 0.06)随着尿毒症血清增加呈线性下降:(见文章)。速尿及其主要代谢产物占放射性速尿部分的97%或更多。代谢产物在血浆或尿液中均未随时间增加。对2只犬(BUN 170和253)急性给予外源性尿素后,CTEA/CF与BUN无关。因此,CF随进行性氮质血症成比例降低,且与RBF、外源性尿素或代谢产物无关。速尿肾小管分泌的这种抑制可能部分解释了速尿在氮质血症中治疗效果降低的原因。

相似文献

1
Effect of experimental azotemia on renal clearance of furosemide in the dog.实验性氮质血症对犬呋塞米肾清除率的影响。
J Pharmacol Exp Ther. 1976 Jan;196(1):238-47.
2
Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.
J Pharmacol Exp Ther. 1976 Dec;199(3):490-7.
3
Effects of azotemia on renal extraction and clearance of PAH and TEA.
Am J Physiol. 1976 Apr;230(4):901-6. doi: 10.1152/ajplegacy.1976.230.4.901.
4
Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.评估血尿素氮和血清肌酐浓度作为肾功能不全指标的研究:111例病例分析及相关文献综述
J Am Vet Med Assoc. 1976 Apr 1;168(7):593-601.
5
Depression of renal clearance of furosemide in man by azotemia.
Clin Pharmacol Ther. 1977 Feb;21(2):141-6. doi: 10.1002/cpt1977212141.
6
Familial azotemia. Impaired urea excretion despite normal renal function.家族性氮质血症。尽管肾功能正常,但尿素排泄受损。
N Engl J Med. 1978 Jan 19;298(3):117-21. doi: 10.1056/NEJM197801192980301.
7
Questionable value of furosemide in preventing renal failure.
Surgery. 1977 Sep;82(3):341-20.
8
Metabolic clearance of furosemide in the rat.
J Pharmacol Exp Ther. 1977 Jan;200(1):52-7.
9
Effect of immunosuppressive drug therapy on blood urea nitrogen concentration in dogs with azotemia.免疫抑制药物疗法对氮血症犬血尿素氮浓度的影响。
J Am Vet Med Assoc. 1984 Sep 15;185(6):664-5.
10
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.

引用本文的文献

1
Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.家犬和家猫的心血管-肾脏轴紊乱:一份兽医共识声明。
J Small Anim Pract. 2015 Sep;56(9):537-52. doi: 10.1111/jsap.12387.
2
Torasemide in advanced renal failure.托拉塞米用于晚期肾衰竭。
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:75-80. doi: 10.1007/BF00877961.
3
Measurement of the renal clearance of drugs.药物肾清除率的测定。
Br J Clin Pharmacol. 1981 Dec;12(6):761-70. doi: 10.1111/j.1365-2125.1981.tb01304.x.
4
Resistance to diuretics: emphasis on a pharmacological perspective.利尿剂抵抗:从药理学角度的重点阐述
Drugs. 1981 Dec;22(6):477-94. doi: 10.2165/00003495-198122060-00004.
5
Resistance to loop diuretics. Why it happens and what to do about it.对袢利尿剂的抵抗。其发生原因及应对措施。
Drugs. 1985 Nov;30(5):427-43. doi: 10.2165/00003495-198530050-00003.
6
Differential effects of the degree of renal damage on p-aminohippuric acid and inulin clearances in rats.肾损伤程度对大鼠对氨基马尿酸和菊粉清除率的不同影响。
J Pharmacokinet Biopharm. 1989 Apr;17(2):169-77. doi: 10.1007/BF01059026.
7
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
J Pharmacokinet Biopharm. 1979 Feb;7(1):1-27. doi: 10.1007/BF01059438.